DyskinesiasDyskinesia, Drug-InducedLevodopaAntiparkinson AgentsParkinson DiseaseGlobus PallidusMovement DisordersChoreaApomorphineAnti-Dyskinesia AgentsPiribedilDopamine AgentsBrain Tissue TransplantationOxidopamineDihydroxyphenylalanineSubthalamic NucleusParkinsonian DisordersParkinson Disease, SecondaryBenserazideAdrenergic Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineFetal Tissue TransplantationMPTP PoisoningMucunaCarbidopaAmantadineDopamine AgonistsCorpus StriatumDeep Brain StimulationThalamic NucleiDystoniaTremorTranquilizing AgentsChronotherapyDopaminePrimidoneElectric Stimulation TherapySaimiriFacial MusclesDystonic DisordersPutamenSubstantia NigraBromocriptineDopamine Plasma Membrane Transport ProteinsMacaca fascicularisBehavior, AnimalNeurologic ExaminationHaloperidolMotion Pictures as Topic2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineBasal GangliaReceptors, Dopamine D2Neurosurgical ProceduresStereotaxic TechniquesReceptors, Dopamine D3Nicotinic AgonistsNeostriatumReceptors, Dopamine D1Stereotyped BehaviorDisease Models, AnimalElectrodes, ImplantedRats, Sprague-DawleyMesencephalonEncephalitisFunctional LateralityAntipsychotic AgentsIntraoperative PeriodDominance, CerebralNeuronsSerotonin Receptor AgonistsAmphetamineAutoradiographyElectrodesMicrodialysisMicroelectrodesReceptors, N-Methyl-D-AspartateNicotine